Journal of Conservative Dentistry
Home About us Editorial Board Instructions Submission Subscribe Advertise Contact e-Alerts Login 
Users Online: 728
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size
 


 
Table of Contents   
ORIGINAL RESEARCH ARTICLE  
Year : 2018  |  Volume : 21  |  Issue : 6  |  Page : 662-666
Antibiofilm efficacy of biosynthesized silver nanoparticles against endodontic-periodontal pathogens: An in vitro study


1 Department of Conservative Dentistry and Endodontics, HKE's SN Institute of Dental Sciences and Research, Kalaburgi, Karnataka, India
2 Department of Conservative Dentistry and Endodontics, College of Dentistry, Gulf Medical University, Ajman, United Arab Emirates
3 Department of Periodontics, HKE's SN Institute of Dental Sciences and Research, Kalaburgi, Karnataka, India
4 Department of Conservative Dentistry and Endodontics, College of Dental Sciences, Davangere, Karnataka, India
5 Department of Microbiology, Gulbarga University, Kalaburgi, Karnataka, India

Click here for correspondence address and email

Date of Submission25-May-2018
Date of Decision31-Jul-2018
Date of Acceptance29-Aug-2018
Date of Web Publication13-Nov-2018
 

   Abstract 

Background: Endodontic-periodontal pathogens exist as biofilms which are difficult to eliminate. Biosynthesized silver nanoparticles (AgNPs) emerged as newer antimicrobial agents with potential benefits.
Aim: The aim of this study is to determine the minimum inhibitory concentration (MIC); evaluate the antibiofilm efficacy of fungal-derived AgNPs against Porphyromonas gingivalis, Bacillus pumilus, and Enterococcus faecalis.
Materials and Methods: MIC of AgNPs against test pathogens was determined using micro broth dilution method. Serial dilutions of AgNPs ranging from 80 to 1 μg/ml concentration were added to wells containing 10 μl of bacterial inoculum in culture media and control group without AgNPs. For biofilm models, 120 dentin blocks were prepared, sterilized, and contaminated for 2 weeks with (n = 40 each). Group 1: B. pumilus, Group 2: E. faecalis, and Group 3: P. gingivalis and each group is divided into four subgroups (n = 10 each) and treated with distilled water, AgNPs, 2% and 0.2% chlorhexidine (CHX). Colonies counted after 24 h of incubation and statistically analyzed using one-way ANOVA and post hoc Tukey tests.
Results: MIC for B. pumilus was determined as 20 μg/ml and 30 μg/ml for E. faecalis and P. gingivalis. AgNPs were effective as 2% CHX against all biofilms compared to control group. Post hoc Tukey test (P < 0.0001) shows no significant difference between groups.
Conclusion: Fungal-derived AgNPs are effective against endo-perio pathogens.

Keywords: Antimicrobial agents; bacterial resistance; biofilm; biosynthesized silver nanoparticles; endo-perio lesions; minimum inhibitory concentration

How to cite this article:
Halkai KR, Halkai R, Mudda JA, Shivanna V, Rathod V. Antibiofilm efficacy of biosynthesized silver nanoparticles against endodontic-periodontal pathogens: An in vitro study. J Conserv Dent 2018;21:662-6

How to cite this URL:
Halkai KR, Halkai R, Mudda JA, Shivanna V, Rathod V. Antibiofilm efficacy of biosynthesized silver nanoparticles against endodontic-periodontal pathogens: An in vitro study. J Conserv Dent [serial online] 2018 [cited 2018 Dec 16];21:662-6. Available from: http://www.jcd.org.in/text.asp?2018/21/6/662/245243

   Introduction Top


Most of the periodontal and endodontic infections are biofilm mediated and have been the subject of intensive research for many years. Bacteria in biofilm exhibit resistance to host defense mechanisms and decreased susceptibility to conventional antimicrobials.[1]

Porphyromonas gingivalis is a Gram-negative, black pigmented, rod-shaped obligate anaerobic microorganism which causes several periodontal diseases and endodontic infections periodontitis.[2] Enterococcus faecalis is a Gram-positive, facultative organism most commonly found in persistent apical or lateral periodontitis and endodontic reinfections. It can survive deep in the dentinal tubules and cementum[3] It possesses several virulence factors which makes it the most resistant microbe[3] Bacillus pumilus is a Gram-positive, aerobic, spore-bearing rod-shaped microorganism found in both periodontal pockets, and root canals associated with severe infections[4] The endo-perio pathogens E. faecalis, P. gingivalis, and B. pumilus forms the biofilms either single or multispecies which are difficult to eradicate.[5],[6]

Recently, biosynthesized silver nanoparticles (AgNPs) have emerged as novel antimicrobial agents owing to their unique chemical and physical properties, smaller size and shape, high surface area to volume ratio, and no bacterial resistance. Hence, show an insight for the management of endodontic, periodontal, or the combined lesions.[7] In our previous study, AgNPs were biosynthesized using endophytic fungi fusarium semitectum and showed efficient antibacterial activity against P. gingivalis, B. pumilus, and E. faecalis[8] The present study aims at evaluating the minimum inhibitory concentration (MIC) of biosynthesized AgNPs and antibacterial efficacy against endo-periopathogens P. gingivalis, B. pumilus, and E. faecalis in biofilm form using dentin blocks.


   Materials and Methods Top


AgNPs were biosynthesized using endophytic fungi Fusarium semitectum and characterized by ultraviolet spectrum, transmission electron microscopy and Fourier transform infrared spectroscopy as described earlier were used in the present study.[8],[9] Briefly, the fungi isolated from healthy leaves of Withania Somnifera (Ashwagandha) were allowed to grow on potato dextrose agar plates. Fresh fungal cultures were inoculated in 100 ml malt glucose yeast peptone broth and incubated at 29°C for 72 h. The fungal biomass was filtered using Whatman filter paper number 1, washed with sterile distilled water and 25 g of fungal biomass was then added to flasks containing 100 ml of sterile distilled water and incubated for 48 h. The cell-free fungal filtrate was mixed with 100 ml of 1 mM concentration AgNO3 solution and kept in the dark at 29°C for 24 h and pH adjusted to 7 was used further.

The American type culture collection strains ([ATCC], Manassas, VA, USA) of B. pumilus (27142) and E. faecalis (29212) strains were sub-cultured on trypticase soy agar (TSA) plates and incubated at 35°C for 24 h. P. gingivalis (33277) strains were subcultured on sterilized TSA supplemented with 5% sheep blood, hemin (5 μg/ml), vitamin K1 (0.5 μg/ml), and yeast extract (10 mg/ml) and incubated at 37°C for 72 h under anaerobic conditions.

MIC of AgNPs against test organisms was determined by micro broth dilution technique as per Clinical and Laboratory Standards guidelines.[10] Each bacterial inoculum was adjusted to 1–2 × 105 cells/ml and 10 μl bacterial inoculum of each test organism was added to wells of microtiter plates with respective culture medium containing 100 μl of series of dilutions of AgNPs ranging from 80 μg/ml to 1 μg/ml. Culture media without AgNPs was used as control group and 10 μl Alamar blue (0.7 mg/ml) was added to all the wells. The treated test plates were incubated at 37°C for 24 h and optical density at 600 OD was measured in plate reader (BioTek, PowerWave XS2, Vermont, USA). The lowest concentration of AgNPs that inhibits the growth of test organisms in comparison to the control group was defined as the MIC value. The experiments were performed in triplicates [Figure 1]a,[Figure 1]b,[Figure 1]c.
Figure 1: Micro broth dilution test plate for minimum inhibitory concentration determination (a) Bacillus pumilus, (b) Enterococcus faecalis and (c) Porphyromonas gingivalis

Click here to view


The antibacterial efficacy of biosynthesized AgNPs against test microorganisms in biofilm form was evaluated using the dentin blocks according to Nascimento et al.[11] with slight modifications. The study was approved by the Institutional Ethical Committee. Overnight grown cultures of test organisms were centrifuged at 6000 rpm for 10 min at 4°C. The supernatants were discarded, and the cells were washed twice in sterile deionized water and suspended in 5 ml of TSA broth for B. pumilus and E. faecalis and in TSA supplemented broth for P. gingivalis and incubated for 4 h at 37°C. Turbidity was adjusted to 1 × 107 cells/ml using a spectrophotometer.

One hundred and twenty dentin blocks were prepared using sixty human extracted single-rooted teeth. The crown and the apical part of the root were sectioned using a rotary diamond disc to obtain the middle third of the root which was vertically sectioned into two halves, and cementum was removed using the diamond bur to obtain the dentin blocks measuring 5 mm × 5 mm × 1 mm (width × length × thickness).

The dentin blocks were treated in an ultrasonic bath of 17% EDTA (Prime Dental Products, Mumbai, India) for 5 min to remove the smear layer followed by 3% sodium hypochlorite (Prime Dental Products, Mumbai, India) for 5 min to remove the organic and inorganic debris and distilled water for another 5 min to remove all the chemicals used and sterilized by autoclaving. The dentin blocks were randomly divided into three groups (n = 40 each) as group 1: B. pumilus (ATCC 27142), Group 2: E. faecalis (ATCC 29212), and Group 3: P. gingivalis (ATCC 33277).

For Groups 1 and 2, each dentin block was placed in individual test tubes containing 1 ml of TSA broth and for Group 3 the dentin blocks were placed in individual test tubes containing TSA supplemented broth and subjected to the second cycle of sterilization.

For bacterial contamination of the dentin blocks, about 50 μl of the bacterial inoculum was transferred to pre-sterilized individual test tubes (n = 40 each) containing dentin blocks in respective broth. The purity of the cultures was checked by subculturing 5 μl from the incubated dentin blocks on respective culture plates. The broth was replenished every alternate day for a period of 2 weeks. After incubation, dentin blocks were washed twice with 5 ml of sterile distilled water. Biofilm models of dentin blocks in each group were randomly divided into four subgroups (n = 10 each) and treated as follows:

  • Group 1: B. pumilus (ATCC 27142) (n = 40)


    • Subgroup 1A: Sterile distilled water (Control)
    • Subgroup 1B: 0.2% CHX
    • Subgroup 1C: 2 % CHX
    • Subgroup 1 D: 20 μg/ml of AgNPs (MIC dose).


  • Group 2: E. faecalis (ATCC 29212) (n = 40)


    • Subgroup 2 A: Sterile distilled water (Control)
    • Subgroup 2B: 0.2% CHX
    • Subgroup 2C: 2 % CHX
    • Subgroup 2D: 30 μg/ml of AgNPs (MIC dose).


  • Group 3: P. gingivalis (ATCC 33277) (n = 40)


    • Subgroup 3A: Sterile distilled water (Control)
    • Subgroup 3B: 0.2% CHX
    • Subgroup 3C: 2 % CHX
    • Subgroup 3D: 30 μg/ml of AgNPs (MIC dose).


After 24 h incubation, each dentin block was rinsed in saline and transferred to micro centrifuge tubes and shaken for 60 s (vortex AP 56). Serial decimal dilutions were prepared, and 50 μl of the dilution were placed on TSA plates for Groups 1 and 2 specimens and on TSA supplemented plates for Group 3 specimens and incubated for 24 h followed by colony forming units (cfu/ml) counting. Data collected was statistically analyzed using One-way ANOVA and Post Hoc Tukey multiple comparison tests [Figure 2].
Figure 2: Biofilm plates of cfu/ml: Group 1 (Bacillus pumilus) 1a: Control, 1b: 0.2% chlorhexidine, 1c: 2% chlorhexidine and 1d: Silver nanoparticles. Group 2 (Enterococcus faecalis) 2a: Control, 2b: 0.2% chlorhexidine, 2c: 2% chlorhexidine and 2d: Silver nanoparticles. Group 3 (Porphyromonas gingivalis) 3a: Control, 3b: 0.2% chlorhexidine, 3c: 2% chlorhexidine and 3d: Silver nanoparticles

Click here to view



   Results Top


All the test microorganisms were sensitive to biosynthesized AgNPs. The mean value of the three readings was calculated as MIC. MIC of AgNPs for B. pumilus was determined as 20 μg/ml and for E. faecalis and P. gingivalis 30 μg/ml respectively.

For antibacterial efficacy in biofilm mode, the mean colony count (cfu/ml [107]) for all the groups was evaluated and shown in [Table 1] and [Table 2]. The results of the present study indicate biosynthesized AgNPs are effective against all the three test microbes when compared to the control group. There is no statistically significant difference between the three groups when compared between groups by Post hoc Tukey multiple comparison test.
Table 1: One-way ANOVA analysis for within groups of all three groups for antibiofilm efficacy

Click here to view
Table 2: P value by one-way ANOVA and post hoc Tukey test to compare antibiofilm efficacy between groups

Click here to view



   Discussion Top


Microorganisms grown in biofilms are difficult to eradicate with existing antimicrobial agents and exhibit resistance.[12] Since endodontic-periodontal infections are biofilm mediated and resistant to existing antimicrobial agents, the present study aims to evaluate the antibacterial efficacy of biosynthesized AgNPs against the biofilms of B. pumilus, E. faecalis and P. gingivalis.

MIC is the lowest concentration of a drug that inhibits the visible growth of the test organism, used to determine the in vitro antibacterial activity of new antimicrobial agents. Different bacterial species have varying MICs. In vitro detection of MIC acts as a guideline for clinical application[13] Although antimicrobial activity of biosynthesized AgNPs was proven on many pathogenic bacteria;[8],[9],[14] Literature is scarce for application of biosynthesized AgNPs for determining MIC and antibacterial efficacy of fungal-derived AgNPs using tooth models against P. gingivalis, B. pumilus, and E. faecalis.[15]

The results of the present study show that AgNPs are effective against test microorganisms with MIC values of 30 μg/ml against P. gingivalis and E. faecalis and 20 μg/ml against B. pumilus. MIC values of AgNPs synthesized using Chamaemelum nobile extract against  Escherichia More Details coli, Staphylococcus aureus and Bacillus subtilis was found to be 7.8, 31.2, and 15.6 μg/ml.[16] MIC of AgNPs-derived from Garcinia imberti against E. faecalis was observed maximum at a concentration of 62.5 mg/ml[17] MIC of fungal-derived AgNPs against E. faecalis biofilm was determined 30 μg/ml with effective antibacterial efficacy.[15] The results of the present study showed effective antibacterial activity against all the test microbes.

In the present study, the MIC dose of AgNPs was standardized to evaluate the antibacterial efficacy against test pathogens in biofilm form because it is the minimum dose which inhibits the visible bacterial growth[13] therefore used to evaluate the efficacy of AgNPs at a minimal dose.

Biosynthesised AgNPs have emerged as newer antimicrobial agents with effective antimicrobial activity against several pathogens.[8],[18]

Chlorhexidine (CHX) is the most effective antimicrobial agent; its effectiveness can be attributed to its substantivity within the oral cavity. It is recommended to use 0.2%–0.12% CHX for plaque control and 2% CHX is recommended as root canal irrigant;[19],[20] hence, both 0.2 and 2% CHX were used in the present study.

Antimicrobial studies on planktonic culture models do not correlate well with clinical findings.[21] Therefore; to ascertain the antibacterial efficacy of AgNPs effectively biofilm model using dentin blocks was evaluated. Human permanent teeth were used to prepare the dentin blocks as they simulate clinical conditions.[22]

E. faecalis biofilm was more resistant to CHX than the same strain grown in planktonic suspension and 2% CHX eliminated most of the E. faecalis biofilms.[23],[24] AgNPs against E. faecalis biofilm using dentin blocks showed less number of viable bacteria for AgNPs compared to CHX.[18] The results of the present study show effective antibacterial activity of biosynthesized against B. pumilus, E. faecalis and P. gingivalis biofilm model at a dose ranging from 20 to 30 μg/ml indicating they can be used as antimicrobial agents in periodontal, endodontic and combined lesions.

Results of the present study show an insight for application of biosynthesized AgNPs for the treatment of endo-perio lesions; can be used as root canal irrigants, intracanal medicaments, root canal sealers, can be incorporated for periodontal therapy alternative to topical antiseptics, antimicrobial agents and for local drug delivery.[7]


   Conclusion Top


The present in vitro study helps to design and develop intervention approaches for controlling periodontal, endodontic or combined lesions incorporating biosynthesized silver nanoparticles. However, in vitro values of MIC may not hold for in vivo conditions as the bacterial growth varies from in vitro and in vivo conditions. In vitro determination of MIC serves as an attempt for quantifying drug activity against the test microorganisms, and the results of the study show biosynthesized AgNPs are effective against biofilms of P. gingivalis, B. pumilus and E. faecalis.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2003;2:114-22.  Back to cited text no. 1
    
2.
Ozbek SM, Ozbek A. Real-time polymerase chain reaction of “red complex” (Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola) in periradicular abscesses. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:670-4.  Back to cited text no. 2
    
3.
Halkai R, Hegde MN, Halkai K. Evaluation of the presence of Enterococcus faecalis in root cementum: A confocal laser scanning microscope analysis. J Conserv Dent 2014;17:119-23.  Back to cited text no. 3
[PUBMED]  [Full text]  
4.
Johnson BT, Shaw LN, Nelson DC, Mayo JA. Extracellular proteolytic activities expressed by Bacillus pumilus isolated from endodontic and periodontal lesions. J Med Microbiol 2008;57:643-51.  Back to cited text no. 4
    
5.
Duggan JM, Sedgley CM. Biofilm formation of oral and endodontic Enterococcus faecalis. J Endod 2007;33:815-8.  Back to cited text no. 5
    
6.
How KY, Song KP, Chan KG. Porphyromonas gingivalis: An overview of periodontopathic pathogen below the gum line. Front Microbiol 2016;7:53.  Back to cited text no. 6
    
7.
Halkai KR, Mudda JA, Shivanna V, Rathod V, Halkai R. Biosynthesized silver nanoparticles from fungi as antimicrobial agents for endo-perio lesions – A review. Ann Res Rev Biol 2016;10:1-7.  Back to cited text no. 7
    
8.
Halkai KR, Mudda JA, Shivanna V, Rathod V, Halkai RS. Evaluation of antibacterial efficacy of biosynthesized silver nanoparticles derived from fungi against endo-perio pathogens Porphyromonas gingivalis, bacillus pumilus, and Enterococcus faecalis. J Conserv Dent 2017;20:398-404.  Back to cited text no. 8
[PUBMED]  [Full text]  
9.
Halkai KR, Mudda JA, Shivanna V, Rathod V, Halkai RS. Biosynthesis, characterization and antibacterial efficacy of silver nanoparticles derived from endophytic fungi against P. gingivalis. J Clin Diagn Res 2017;11:ZC92-96.  Back to cited text no. 9
    
10.
Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 9th ed. Wayne, PA, USA: Clinical and Laboratory Standards Institute Document M07-A9, Clinical and Laboratory Standards Institute; 2012.  Back to cited text no. 10
    
11.
Nascimento CA, Tanomaru-Filho M, Faria-Junior NB, Faria G, Guerreiro-Tanomaru JM. Antimicrobial activity of root canal irrigants associated with cetrimide against biofilm and planktonic Enterococcus faecalis. J Contemp Dent Pract 2014;15:603-7.  Back to cited text no. 11
    
12.
Kishen A. Advanced therapeutic options for endodontic biofilms. Endod Topics 2012;22:99-123.  Back to cited text no. 12
    
13.
Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001;48 Suppl 1:5-16.  Back to cited text no. 13
    
14.
Halkai KR, Mudda JA, Shivanna V, Rathod V, Halkai R. Evaluation of antibacterial efficacy of fungal-derived silver nanoparticles against Enterococcus faecalis. Contemp Clin Dent 2018;9:45-8.  Back to cited text no. 14
[PUBMED]  [Full text]  
15.
Halkai KR, Mudda JA, Shivanna V, Rathod V, Halkai R. Antibacterial efficacy of biosynthesized silver nanoparticles against Enterococcus faecalis biofilm: An in vitro study. Contemp Clin Dent 2018;9:237-41.  Back to cited text no. 15
[PUBMED]  [Full text]  
16.
Erjaee H, Rajaian H, Nazifi S. Synthesis and characterization of novel silver nanoparticles using Chamaemelum nobile extract for antibacterial application. Adv Nat Sci Nanosci Nanotechnol 2017;8:1-9.  Back to cited text no. 16
    
17.
Levison ME. Pharmacodynamics of antimicrobial drugs. Infect Dis Clin North Am 2004;18:451-65, vii.  Back to cited text no. 17
    
18.
Ninganagouda S, Rathod V, Jyoti H, Singh D, Kulkarni P, Haq MU. Extracellular biosynthesis of silver nanoparticles using Aspergillus flavus and their antimicrobial activity against gram negative MDR strains. Int J Pharma Bio Sci 2013;4:222-9.  Back to cited text no. 18
    
19.
Deshpande N, Amrutiya Mansi R. Comparative evaluation of anti-microbial efficacy of green tea extract and chlorhexidine mouthwash on red complex, orange complex and green complex periodontal pathogens – An in vitro study. Int J Innov Dent Sci 2017;2:1-12.  Back to cited text no. 19
    
20.
Leonardo MR, Tanomaru Filho M, Silva LA, Nelson Filho P, Bonifácio KC, Ito IY, et al. In vivo antimicrobial activity of 2% chlorhexidine used as a root canal irrigating solution. J Endod 1999;25:167-71.  Back to cited text no. 20
    
21.
Gomes BP, Ferraz CC, Vianna ME, Berber VB, Teixeira FB, Souza-Filho FJ, et al. In vitro antimicrobial activity of several concentrations of sodium hypochlorite and chlorhexidine gluconate in the elimination of Enterococcus faecalis. Int Endod J 2001;34:424-8.  Back to cited text no. 21
    
22.
Wu D, Fan W, Kishen A, Gutmann JL, Fan B. Evaluation of the antibacterial efficacy of silver nanoparticles against Enterococcus faecalis biofilm. J Endod 2014;40:285-90.  Back to cited text no. 22
    
23.
Abdullah M, Ng YL, Gulabivala K, Moles DR, Spratt DA. Susceptibilties of two Enterococcus faecalis phenotypes to root canal medications. J Endod 2005;31:30-6.  Back to cited text no. 23
    
24.
Lima KC, Fava LR, Siqueira JF Jr. Susceptibilities of Enterococcus faecalis biofilms to some antimicrobial medications. J Endod 2001;27:616-9.  Back to cited text no. 24
    

Top
Correspondence Address:
Dr. Kiran R Halkai
Department of Conservative Dentistry and Endodontics, HKE's SN Institute of Dental Sciences and Research, Kalaburgi, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JCD.JCD_203_18

Rights and Permissions


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
 
 
 
  Search
 
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  
 


    Abstract
   Introduction
    Materials and Me...
   Results
   Discussion
   Conclusion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed93    
    Printed0    
    Emailed0    
    PDF Downloaded33    
    Comments [Add]    

Recommend this journal